source
- Encoded Therapeutics gene therapy cuts seizures 76% in Dravet syndrome childrenEncoded Therapeutics presented data at the ASGCT26 meeting showing its gene therapy achieved a 76% reduction in seizures among children with Dravet syndrome. The result was observed in three patie…
- Degron Therapeutics raises $40M in Series A extension, total $95M, as Cabaletta releases early CAR‑T dataDegron Therapeutics, a US‑China biotech focused on molecular‑glue degrader technology, announced an additional $40 million in Series A extension funding, bringing its total capital raised to $95 mi…